Optogenetic Membrane Polymerization for Long-Term Neuronal Excitability
Find Innovative SolutionsGenerate Solutions
Solution Overview
Problem
Existing methods for modulating neuronal excitability lack genetic specificity and specificity in neuronal circuits, and there is a need for strategies to increase or decrease membrane excitability while minimizing toxic side reactions.
Innovation Solution
The use of optogenetic polymerization and assembly of electroactive polymers on specified cellular membranes, involving the expression of a mini Singlet Oxygen Generator (miniSOG) in neuronal cells with monomers like 3,3′-diaminobenzidine or aniline, followed by irradiation to induce polymerization of poly(3,3′-diaminobenzidine or polyaniline, to modulate neuronal activity.
Engineering Contradictions & Design Principles
Engineering Contradiction Analysis
1Duration of action of moving object
If conventional optogenetic stimulation using ion channels is used, then millisecond-timescale neuronal excitation and inhibition can be achieved, but long-term modulation of neuronal excitability cannot be achieved
Solution Approach 1:
The invention changes the fundamental parameter being manipulated from ion channel conductivity (transient) to membrane capacitance (long-term). By incorporating electroactive polymers into the neuronal membrane, the capacitance is permanently altered, enabling long-term modulation of neuronal excitability that persists beyond the duration of optical stimulation.
Solution Approach 2:
The invention segments the modulation function into two distinct components: (1) a genetically targeted optogenetic initiation system that provides spatial and temporal precision, and (2) a polymer incorporation system that provides long-term persistence. This segmentation allows each component to optimize for its specific function while working together to achieve both precision and durability.
2Stability of the object's composition
If prefabricated nanomaterials are incorporated onto cellular membranes, then membrane capacitance can be modulated, but genetic specificity in neuronal circuits cannot be achieved
Solution Approach 1:
The invention introduces an intermediary system consisting of optogenetically controlled enzymes (peroxidases) that are genetically targeted to specific neuronal cell types. These enzymes serve as mediators that convert non-specific polymer monomers into polymer products only at the desired locations, thereby achieving both membrane capacitance modulation and genetic specificity through the intermediary enzymatic step.
Solution Approach 2:
The invention replaces the mechanical/physical approach of directly incorporating prefabricated nanomaterials with a biochemical synthesis approach. Instead of physically depositing polymers, the system uses optogenetically activated enzymatic reactions to synthesize polymers in situ, allowing for greater precision and compatibility with biological systems.
3Manufacturing precision
If in vivo synthesis of functional nanomaterials is used, then control over location and integration at cellular level can be improved, but toxic side reactions may increase
Solution Approach 1:
The invention uses periodic or pulsed optical activation to control the polymerization process. By activating the optogenetic enzymes only during specific time windows and only in specific locations where light is delivered, the system minimizes the overall exposure to toxic monomers and reactive oxygen species, thereby reducing side reactions while maintaining synthesis precision.
Solution Approach 2:
The optogenetic enzymes act as intermediaries that control where and when polymerization occurs. This intermediary control allows the system to confine toxic reactions to specific subcellular compartments and time periods, rather than allowing diffuse toxic effects throughout the cell. The enzymes effectively compartmentalize the toxic process spatially and temporally.
Applied Scientific Principles
This section explains which scientific principles are used to turn an abstract innovation direction into a practical engineering solution.
Function Achieved in This Case
This approach provides spatiotemporal control of polymerization at nanometer-level spatial resolution, altering neuronal excitability with long-term electrophysiological changes, and can treat disorders such as neurodegenerative diseases and chronic pain by increasing or decreasing action potential firing in response to depolarizing stimuli.
Implementation Method 1
irradiating at least a portion of the neuronal cell to induce polymerization of poly(3,3′-diaminobenzidine) or polyaniline
Implementation Method 2
expressing in a neuronal cell a vector comprising a mini Singlet Oxygen Generator (miniSOG) in the presence of monomers of 3,3′-diaminobenzidine or aniline
Data Source
AI summary
The invention features compositions and methods for treating diseases or disorders associated with undesirable neuronal excitability (e.g., neurodegenerative disease, such as Parkinson's disease or Huntington's disease; or chronic pain, or epilepsy).